Published in Cancers (Basel) on November 05, 2013
Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies. J Clin Oncol (2015) 0.92
CYP24A1 expression inversely correlates with melanoma progression: clinic-pathological studies. Int J Mol Sci (2014) 0.88
The association between pre-treatment serum 25-hydroxyvitamin D and survival in newly diagnosed stage IV prostate cancer. PLoS One (2015) 0.82
The relationship between circulating 25-hydroxyvitamin D and survival in newly diagnosed advanced non-small-cell lung cancer. BMC Cancer (2015) 0.81
Does sufficient evidence exist to support a causal association between vitamin D status and cardiovascular disease risk? An assessment using Hill's criteria for causality. Nutrients (2014) 0.80
Vitamin D as a Resilience Factor, Helpful for Survival of Potentially Fatal Conditions: A Hypothesis Emerging from Recent Findings of the ESTHER Cohort Study and the CHANCES Consortium. Nutrients (2015) 0.78
A protocol for prospective studies of 25-hydroxyvitamin D, leptin and body mass index in relation to cutaneous melanoma incidence and survival. BMJ Open (2017) 0.75
Vitamin D deficiency. N Engl J Med (2007) 59.34
THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION? Proc R Soc Med (1965) 40.52
Nonclassic actions of vitamin D. J Clin Endocrinol Metab (2008) 3.71
Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol (1980) 3.25
Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol (2008) 3.17
Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma. J Clin Oncol (2009) 2.85
Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med (2007) 2.83
Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol (2007) 2.52
Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol (2009) 2.49
Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer (2011) 2.43
Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2002. BMC Cancer (2006) 2.38
Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 2.25
A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study. J Clin Endocrinol Metab (2012) 2.16
Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. J Clin Oncol (2010) 2.06
Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control (2004) 2.04
Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res (1990) 2.00
Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood (2010) 1.83
Randomized clinical trial of vitamin D3 doses on prostatic vitamin D metabolite levels and ki67 labeling in prostate cancer patients. J Clin Endocrinol Metab (2013) 1.81
Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev (1998) 1.69
Cancer survival is dependent on season of diagnosis and sunlight exposure. Int J Cancer (2006) 1.64
Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741. J Clin Oncol (2011) 1.64
Association between serum 25(OH)D and death from prostate cancer. Br J Cancer (2009) 1.55
Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment. J Steroid Biochem Mol Biol (2005) 1.45
Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer. J Clin Oncol (2008) 1.42
Anti-tumor activity of calcitriol: pre-clinical and clinical studies. J Steroid Biochem Mol Biol (2004) 1.35
Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev (2010) 1.30
Calcium modulation of hypertension and obesity: mechanisms and implications. J Am Coll Nutr (2001) 1.30
Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer. PLoS One (2011) 1.25
Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role? Lung Cancer (2007) 1.21
Relationship between cancer mortality/incidence and ambient ultraviolet B irradiance in China. Cancer Causes Control (2010) 1.21
Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations. Cancer Epidemiol Biomarkers Prev (2012) 1.20
Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control (2011) 1.18
25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. Cancer Epidemiol Biomarkers Prev (2000) 1.18
Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res (2011) 1.16
How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer?: An examination using Hill's criteria for causality. Dermatoendocrinol (2009) 1.13
Vitamin D and breast cancer recurrence in the Women's Healthy Eating and Living (WHEL) Study. Am J Clin Nutr (2010) 1.12
Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency. Carcinogenesis (2012) 1.12
Serum vitamin D levels and survival of patients with colorectal cancer: post-hoc analysis of a prospective cohort study. BMC Cancer (2010) 1.09
Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer. Int J Colorectal Dis (2008) 1.07
Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer. J Transl Med (2012) 1.05
Prostate cancer, serum parathyroid hormone, and the progression of skeletal metastases. Cancer Epidemiol Biomarkers Prev (2008) 1.03
Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer. Endocrinology (2012) 1.00
Season of diagnosis is a prognostic factor in Hodgkin's lymphoma: a possible role of sun-induced vitamin D. Br J Cancer (2005) 0.97
The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer. Clin Cancer Res (2000) 0.92
Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients. Int J Cancer (2010) 0.92
Vitamin D insufficiency in myeloproliferative neoplasms and myelodysplastic syndromes: clinical correlates and prognostic studies. Am J Hematol (2011) 0.88
Serum calcium, tumor size, and hormone receptor status in women with untreated breast cancer. Cancer Biol Ther (2012) 0.85
Vitamin D and overall mortality. Pigment Cell Melanoma Res (2012) 0.84
Relationship between cancer survival and ambient ultraviolet B irradiance in China. Cancer Causes Control (2013) 0.84
Correlates of 25-hydroxyvitamin D and breast cancer stage in the Women's Healthy Eating and Living Study. Nutr Cancer (2013) 0.80
Prospective studies of total and ionized serum calcium in relation to incident and fatal ovarian cancer. Gynecol Oncol (2013) 0.80
Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res (2005) 3.13
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst (2005) 2.99
Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst (2007) 2.08
Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control (2004) 2.04
Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum (2004) 2.01
Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway. Lancet Oncol (2009) 1.95
Association between vitamin D status and physical performance: the InCHIANTI study. J Gerontol A Biol Sci Med Sci (2007) 1.84
Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. PLoS Med (2009) 1.83
Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev (2004) 1.82
Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am J Epidemiol (2007) 1.68
Residential sunlight exposure is associated with a decreased risk of prostate cancer. J Steroid Biochem Mol Biol (2004) 1.64
The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program. Cancer (2004) 1.62
Risk factors for hypospadias in Norwegian boys - association with testicular dysgenesis syndrome? Int J Androl (2004) 1.61
Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women. Cancer Causes Control (2005) 1.55
Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. J Natl Cancer Inst (2003) 1.55
Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol (2004) 1.54
Height and body mass index in relation to esophageal cancer; 23-year follow-up of two million Norwegian men and women. Cancer Causes Control (2004) 1.51
Head circumference at birth and risk of brain cancer in childhood: a population-based study. Lancet Oncol (2006) 1.50
Breast cancer tumor growth estimated through mammography screening data. Breast Cancer Res (2008) 1.43
Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J Cancer (2007) 1.43
Age-incidence curves of nasopharyngeal carcinoma worldwide: bimodality in low-risk populations and aetiologic implications. Cancer Epidemiol Biomarkers Prev (2008) 1.38
Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev (2010) 1.37
Metabolic profile, physical activity, and mortality in breast cancer patients. Breast Cancer Res Treat (2009) 1.36
25-Hydroxyvitamin D, parathyroid hormone, and mortality in black and white older adults: the health ABC study. J Clin Endocrinol Metab (2012) 1.33
Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults. Int J Cancer (2011) 1.31
Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results. J Med Screen (2005) 1.29
Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program. Cancer (2013) 1.25
Cadmium and renal cancer. Toxicol Appl Pharmacol (2005) 1.22
Cancer's impact on employment and earnings--a population-based study from Norway. J Cancer Surviv (2008) 1.20
Serum calcium and incident and fatal prostate cancer in the National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev (2008) 1.18
Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control (2011) 1.18
Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women. Am J Epidemiol (2006) 1.17
Cancer risk in children with birth defects and in their families: a population based cohort study of 5.2 million children from Norway and Sweden. Cancer Epidemiol Biomarkers Prev (2008) 1.16
Frailty modelling of testicular cancer incidence using Scandinavian data. Biostatistics (2004) 1.15
Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can). Cancer Causes Control (2011) 1.14
Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can). Gynecol Oncol (2012) 1.11
Sun exposure and prostate cancer risk: evidence for a protective effect of early-life exposure. Cancer Epidemiol Biomarkers Prev (2007) 1.09
Prospective study on metabolic factors and risk of prostate cancer. Cancer (2012) 1.09
Cadmium and prostate cancer: a critical epidemiologic analysis. Cancer Invest (2005) 1.08
Estimating mean sojourn time and screening sensitivity using questionnaire data on time since previous screening. J Med Screen (2008) 1.05
Parenthood after cancer - a population-based study. Psychooncology (2007) 1.05
Frailty modelling of colorectal cancer incidence in Norway: indications that individual heterogeneity in risk is related to birth cohort. Eur J Epidemiol (2006) 1.05
Risk of bilateral renal cell cancer. J Clin Oncol (2009) 1.04
Blood pressure and risk of cancer incidence and mortality in the Metabolic Syndrome and Cancer Project. Hypertension (2012) 1.04
A prospective study of total and ionized serum calcium and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev (2009) 1.04
Solar radiation, vitamin D and survival rate of colon cancer in Norway. J Photochem Photobiol B (2005) 1.04
Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project. Cancer Epidemiol Biomarkers Prev (2010) 1.03
Hypercholesterolemia and prostate cancer: a hospital-based case-control study. Cancer Causes Control (2008) 1.01
25-Hydroxyvitamin D-1alpha-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer. J Steroid Biochem Mol Biol (2002) 1.01
Ochratoxin A: in utero exposure in mice induces adducts in testicular DNA. Toxins (Basel) (2010) 1.01
Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study. Cancer Causes Control (2010) 1.01
The prostate 25-hydroxyvitamin D-1 alpha-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin D. Carcinogenesis (2004) 1.01
25-hydroxyvitamin D status and change in physical performance and strength in older adults: the Health, Aging, and Body Composition Study. Am J Epidemiol (2012) 1.01
Fetal growth and childhood cancer: a population-based study. Pediatrics (2013) 1.01
A prospective study of body mass index, weight change, and risk of cancer in the proximal and distal colon. Cancer Epidemiol Biomarkers Prev (2010) 1.00
Metabolic syndrome and endometrial carcinoma. Am J Epidemiol (2010) 0.99
Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can). Cancer (2010) 0.99
Blood pressure and other metabolic syndrome factors and risk of brain tumour in the large population-based Me-Can cohort study. J Hypertens (2012) 0.98
Conditions in utero and cancer risk. Eur J Epidemiol (2006) 0.98
Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can). PLoS One (2013) 0.98
The impact of height and body mass index on the risk of testicular cancer in 600,000 Norwegian men. Cancer Causes Control (2006) 0.98
Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can). Int J Cancer (2011) 0.96
Risk of thyroid cancer in first-degree relatives of patients with non-medullary thyroid cancer by histology type and age at diagnosis: a joint study from five Nordic countries. J Med Genet (2013) 0.95
Protective effects of low calcium intake and low calcium absorption vitamin D receptor genotype in the California Collaborative Prostate Cancer Study. Cancer Epidemiol Biomarkers Prev (2012) 0.95
Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project. BMC Cancer (2014) 0.95
Preliminary report: vitamin D deficiency in advanced cancer patients with symptoms of fatigue or anorexia. Oncologist (2011) 0.94
Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer--a large nested case-control study within the JANUS cohort in Norway. Int J Cancer (2013) 0.94
Size at birth and risk of breast cancer: prospective population-based study. Int J Cancer (2005) 0.93
Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway. Cancer Epidemiol Biomarkers Prev (2008) 0.93
Breast cancer incidence in Mongolia. Cancer Causes Control (2012) 0.92
Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project. Int J Epidemiol (2011) 0.92
Frailty modeling of the bimodal age-incidence of Hodgkin lymphoma in the Nordic countries. Cancer Epidemiol Biomarkers Prev (2011) 0.92
Reproductive history and the risk of molecular breast cancer subtypes in a prospective study of Norwegian women. Cancer Causes Control (2014) 0.92
A hierarchical frailty model for familial testicular germ-cell tumors. Am J Epidemiol (2013) 0.91
Calcium and vitamin D supplementation during androgen deprivation therapy for prostate cancer: a critical review. Oncologist (2012) 0.91
The associations of obesity, lymph node status and prognosis in breast cancer patients: dependence on estrogen and progesterone receptor status. APMIS (2004) 0.90
Calcium intake and prostate cancer among African Americans: effect modification by vitamin D receptor calcium absorption genotype. J Bone Miner Res (2012) 0.90
Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrations. Epidemiology (2014) 0.89
Metabolic factors associated with risk of renal cell carcinoma. PLoS One (2013) 0.89
The impact of cancer on spouses' labor earnings: a population-based study. Cancer (2009) 0.88
Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes Control (2013) 0.88
Serum folate and vitamin B12 concentrations in relation to prostate cancer risk--a Norwegian population-based nested case-control study of 3000 cases and 3000 controls within the JANUS cohort. Int J Epidemiol (2013) 0.87
Does cancer in a child affect parents' employment and earnings? A population-based study. Cancer Epidemiol (2010) 0.86
Dietary calcium and risk for prostate cancer: a case-control study among US veterans. Prev Chronic Dis (2012) 0.86
Overdiagnosis of invasive breast cancer due to mammography screening. Ann Intern Med (2012) 0.85
Consumption of berries, fruits and vegetables and mortality among 10,000 Norwegian men followed for four decades. Eur J Nutr (2014) 0.85
Serum calcium, tumor size, and hormone receptor status in women with untreated breast cancer. Cancer Biol Ther (2012) 0.85
Estimating screening test sensitivity and tumour progression using tumour size and time since previous screening. Stat Methods Med Res (2010) 0.85
Homogeneous prostate cancer mortality in the Nordic countries over four decades. Eur Urol (2010) 0.85
Tuberculin status, socioeconomic differences and differences in all-cause mortality: experience from Norwegian cohorts born 1910-49. Int J Epidemiol (2009) 0.85
Recent clinical trials of vitamin D3 supplementation and serum calcium levels in humans: Implications for vitamin D-based chemoprevention. Curr Opin Investig Drugs (2010) 0.84
Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can). Cancer Causes Control (2012) 0.84
Calcium and vitamin D supplementation and loss of bone mineral density in women undergoing breast cancer therapy. Crit Rev Oncol Hematol (2013) 0.84
Challenges and opportunities in research on early-life events/exposures and cancer development later in life. Cancer Causes Control (2012) 0.83
Frailty modeling of bimodal age-incidence curves of nasopharyngeal carcinoma in low-risk populations. Biostatistics (2009) 0.83
Serum calcium levels are elevated among women with untreated postmenopausal breast cancer. Cancer Causes Control (2009) 0.83
Vitamin D status and cancer incidence and mortality: something new under the sun. J Natl Cancer Inst (2006) 0.83
Is serum calcium a biomarker of fatal prostate cancer? Future Oncol (2009) 0.83
Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer? APMIS (2009) 0.83